Fibroblasten-Interferon-Therapie (Hu IFN-?) bei Non-Hodgkin-Lymphomen (NHL) mit niedrigem Malignit�tsgrad: Vorl�ufige Ergebnisse

Authors :: H. Hutsteiner
Wolfgang Wilmanns
Gert Riethmüller
W. Siegert
I. Wüst
H. Theml
B. Emmerich
Dieter Huhn
Ulrich Fink
W. E. Berdel
Johann Rastetter
Source :: Blut. 44:121-124
Publication Year :: 1982
Publisher :: Springer Science and Business Media LLC, 1982.
Abstract: Preliminary results of a cooperative pilot study on the effect of fibroblast interferon in 10 patients with NHL of low-grade malignancy are presented. In eight patients lymphoma progression forced a discontinuation of therapy. At the end of interferon treatment one patient with CBCC showed a stable disease, one patient with CBCC a minor partial remission.

Subjects :: Oncology
medicine.medical_specialty
Pathology
Hematology
business.industry
Fibroblast Interferon
General Medicine
Malignancy
medicine.disease
Low grade malignancy
Discontinuation
Lymphoma
Interferon
hemic and lymphatic diseases
Internal medicine
medicine
In patient
business
medicine.drug

Tools